GeneTex

  • Country / Location Selection

United States (US)

KAL1 blocking peptide

Cat. No. GTX32013-PEP

Application

 Neutralizing/Inhibition
Package
50 μg ($139)
See all KAL1 products
PRODUCT

Summary

KAL1 peptide is used for blocking the activity of KAL1 antibody (catalog number GTX32013).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Anosmin 1 , Admlx , Hh1 , Hha , Kal , Kal1 , Kalig-1 , Kms , Wfdc19 , Anos1

Background

Mutations in this gene cause the X-linked Kallmann syndrome. The encoded protein is similar in sequence to proteins known to function in neural cell adhesion and axonal migration. In addition, this cell surface protein is N-glycosylated and may have anti-protease activity. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for KAL1 blocking peptide (GTX32013-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for KAL1 blocking peptide (GTX32013-PEP). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139